Steven Cohen Gilead Sciences, Inc. Transaction History

Point72 Asset Management, L.P.

$40.1 Billion
Q1 2025

A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 510,736 shares of GILD stock, worth $56.2 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

510,736

Previous 856,657 40.38%

Holding current value

$56.2 Million

Previous $79.1 Million 27.68%

% of portfolio

0.14%

Previous 0.19%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$89.14 - $117.41 $30.8 Million - $40.6 Million	-345,921 Reduced 40.38%	510,736 $57.2 Million
Q4 2024 Feb 14, 2025	SELL	$83.95 - $97.9 $122 Million - $142 Million	-1,448,613 Reduced 62.84%	856,657 $79.1 Million
Q3 2024 Nov 14, 2024	BUY	$66.59 - $83.99 $119 Million - $151 Million	1,793,145 Added 350.14%	2,305,270 $193 Million
Q2 2024 Aug 14, 2024	BUY	$63.15 - $72.88 $9.76 Million - $11.3 Million	154,525 Added 43.21%	512,125 $35.1 Million
Q1 2024 May 15, 2024	BUY	$71.58 - $87.29 $25.6 Million - $31.2 Million	357,600 New	357,600 $26.2 Million
Q3 2023 Nov 14, 2023	BUY	$73.94 - $80.67 $44,511 - $48,563	602 New	602 $45,000
Q1 2023 May 15, 2023	BUY	$77.31 - $88.08 $3.6 Million - $4.1 Million	46,585 New	46,585 $3.87 Million
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $33.5 Million - $38.3 Million	562,900 New	562,900 $34.7 Million
Q2 2022 Aug 15, 2022	SELL	$57.72 - $65.01 $7.22 Million - $8.13 Million	-125,000 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$57.92 - $72.58 $7.24 Million - $9.07 Million	125,000 New	125,000 $7.43 Million
Q2 2021 Aug 16, 2021	SELL	$63.47 - $69.35 $115 Million - $126 Million	-1,813,444 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$60.0 - $68.46 $72.1 Million - $82.2 Million	1,201,301 Added 196.25%	1,813,444 $117 Million
Q4 2020 Feb 16, 2021	BUY	$56.65 - $64.55 $34.7 Million - $39.5 Million	612,143 New	612,143 $35.7 Million
Q1 2020 May 15, 2020	SELL	$62.63 - $80.22 $25.2 Million - $32.3 Million	-402,631 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$61.62 - $67.78 $24.8 Million - $27.3 Million	402,631 New	402,631 $26.2 Million
Q3 2019 Nov 15, 2019	SELL	$62.51 - $69.0 $631,351 - $696,900	-10,100 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$61.87 - $69.38 $624,887 - $700,738	10,100 New	10,100 $682,000
Q1 2019 May 15, 2019	SELL	$62.53 - $70.05 $34.3 Million - $38.5 Million	-548,917 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$60.54 - $79.0 $42.3 Million - $55.2 Million	-698,365 Reduced 55.99%	548,917 $34.3 Million
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $137 Million - $152 Million	-1,923,449 Reduced 60.66%	1,247,282 $96.3 Million
Q2 2018 Aug 14, 2018	BUY	$64.88 - $75.68 $5.98 Million - $6.98 Million	92,165 Added 2.99%	3,170,731 $225 Million
Q1 2018 May 15, 2018	BUY	$72.84 - $88.8 $207 Million - $252 Million	2,836,662 Added 1172.64%	3,078,566 $232 Million
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $17.2 Million - $20.2 Million	241,904	241,904 $17.3 Million

Others Institutions Holding GILD

# of Institutions

2,289

Shares Held

997M

Call Options Held

9.62M

Put Options Held

10M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $138B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track Steven Cohen's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Account